The Allen Institute has launched a major global scientific research initiative, the Brain Health accelerator, in collaboration with some 30 organizations and institutions, to understand the drivers of brain disease at the level of cells and the circuits they form.
Its goal is to identify the precise cell types and circuits that are affected by disease and better understand how these diseases progress in the human brain, and with that knowledge, accelerate the development of genetic therapies that home in on their targets with molecular precision and rescue and protect cells that are vulnerable.